维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="HAVRILESKY L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence 显示文摘	Havrilesky L J Whitehead C M Rubatt J M	2008	Gynecol Oncol2008，110，3：	1
2	Evaluation of biomar -ker panels for early stage ovarian cancer detection and monitoring for disease recurrence显示文摘	Havrilesky L J Whitehead C M Rubatt J M	2008	GynecolOneol2008，110，3：	1
3	Retrospec- tive analysis of selective lymphadenectomy in apparent early- stage endometrial cancer 显示文摘	Cragun J M Havrilesky L J Calillgaert B	2005	J Clin Oncol2005，23，16：	1
4	Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence显示文摘	Havrilesky L J Whitehead C M Rubatt J M	2008	Gynecol 0ncol2008，110，3：	1
5	Prognostic significance of p53 mutation and p53 over expression in advanced epithelial ovarian cancer: a gynecologic oncology group study显示文摘	Havrilesky L Darcy M Hamdan H	2003	J Clin Oncol2003，21，20：	1
6	Path-ogenesis of ovarian cancers 显示文摘	BERCHUCK A ELBENDARY A HAVRILESKY L	1994	J Soc Gynecol Investig1994，1，3：	1
7	Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence 显示文摘	Havrilesky L J Whitehead C M Rubatt J M	2008	Gynecol Oncol2008，110，3：	1
8	Radical hysterecto my and pelvic lymphadenectomy for stage IB2 cervical cancer 显示文摘	Havrilesky L J Leath C A Huh W	2004	Gynecol Oncol2004，93，2：	1
9	Prognostic sig-nificance of p53 mutation and p53 overexpression in ad- vanced epithelial ovarian cancer: a Gynecologic Oncology Group Study 显示文摘	Havrilesky L Darcy M Hamdan H	2003	J Clin Oncol2003，21，：	1
10	PDG- PET for management of cervical and ovarian cancer显示文摘	HAVRILESKY L J KULASINGAM S L MATCHAR D B	2005	Gynecol OncoI2005，97，1：	1
11	Loss of expression of the Pl6 tumor suppressor gene is more frequent in advanced ovarian cancers lacking P53 mutations 显示文摘	Havrilesky L J Alvares AA Whitaker RS	2001	Gynecol Oncol2001，83，：	1
12	Prognostic significiane of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer:a Gynecologic Oncology Group Study显示文摘	Havrilesky L Darcy M Hamdan H	2003	J Clin Oncol2003，21，20：	1
13	Pathogenesis of ovarian cancers显示文摘	BERCHUCK A ELBENDARY A HAVRILESKY L	1994	Journal of the Society for Gynecologic Investigation1994，1，3：	1
14	Evaluation of biomarker panels for early stage ovarian cancer detect ion and m onitoring for disease recurrence 显示文摘	Havrilesky L J W hitch cad C M Rubatt J M	2008	Gynecol Oncol2008，110，03：	1
15	FDG PET for management of cervical and ovarian cancer显示文摘	Havrilesky L J Kulasingam S L Matchar D B	2005	Gynecol Oncol2005，97，1：	1
16	Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer:a gynecologic oncology group study显示文摘	Havrilesky L Darcy KM Hamdan H	2003	J Clin Oncol2003，21，20：	1
17	Evaluation of biomarker panels for early stage ovarian cancer detection and mo- nitoring for disease recurrence显示文摘	Havrilesky L J Whitehead C M Rubatt J M	2008	Gyneeol Oncol2008，110，03：	1
18	Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence显示文摘	Havrilesky L J Whitehead C M Rubatt J M	2008	Gynecol Onco12008，110，3：	1
19	Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence显示文摘	HAVRILESKY L J WHITEHEAD C M RUBATT J M	2008	Gynecol Oncol2008，110，3：	1
20	Predictors of clinical outcomes in the laparoscopic management of adnexal masses显示文摘	HAVRILESKY LAURA J PETERSON BERCEDIS L DRYDEN DAMLA K	2003	Obstet Gynecol2003，102，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示